Fishbein J M, Rosengard B R, Gianello P, Nickeleit V, Guzzetta P C, Smith C V, Nakajima K, Vitiello D, Hill G M, Sachs D H
Transplantation Biology Research Center, Massachusetts General Hospital, Boston 02129.
Transplantation. 1994 May 15;57(9):1303-8. doi: 10.1097/00007890-199405150-00002.
Our laboratory has reported previously spontaneous acceptance of class II-matched, single haplotype (but not 2 haplotype), class I-mismatched renal allografts in miniature swine. All class II-mismatched animals rejected acutely regardless of class I matching. We have also demonstrated recently that a short course of high dose (10 mg/kg/day for 12 days) CsA uniformly induces donor-specific tolerance to 2-haplotype, class I-mismatched renal allografts. The survival of 2-haplotype, fully MHC mismatched renal allografts was prolonged by the same treatment, but tolerance was not induced, as all animals rejected eventually. We have now tested this short course of immunosuppressive therapy for its effect on renal allografts mismatched selectively for 2 haplotypes at class II. We have observed long-term graft survival in 5 of 7 animals under these conditions. Each of the 5 acceptor animals was demonstrated to be specifically tolerant by its response either to donor-matched skin grafts or to a second donor-matched kidney transplant without further immunosuppression. These data suggest the existence of a common pathway for induction of specific transplantation tolerance to MHC antigens when these antigens are recognized on vascular endothelium under conditions of altered cytokine production. They also suggest that tolerance induction under these conditions requires matching for either class I or class II antigens, which may have implications for the mechanism by which peripheral tolerance is induced, as well as practical implications for the extension of these results to potential clinical practice.
我们实验室先前报道过,小型猪可自发接受II类匹配、单倍型(而非2个单倍型)、I类不匹配的肾移植。所有II类不匹配的动物均会急性排斥,无论I类是否匹配。我们最近还证明,短期高剂量(10毫克/千克/天,共12天)环孢素A可一致诱导对2个单倍型、I类不匹配的肾移植产生供体特异性耐受。相同治疗可延长2个单倍型、完全MHC不匹配的肾移植的存活时间,但未诱导出耐受,因为所有动物最终都会排斥。我们现在测试了这种短期免疫抑制疗法对仅在II类有2个单倍型不匹配的肾移植的影响。在这些条件下,我们观察到7只动物中有5只实现了长期移植存活。通过对供体匹配的皮肤移植或第二次供体匹配的肾移植的反应,证实了5只受体动物中的每一只在无进一步免疫抑制的情况下都具有特异性耐受。这些数据表明,当在细胞因子产生改变的条件下在血管内皮上识别这些抗原时,存在诱导对MHC抗原产生特异性移植耐受的共同途径。它们还表明,在这些条件下诱导耐受需要I类或II类抗原匹配,这可能对外周耐受的诱导机制有影响,以及对将这些结果扩展到潜在临床实践有实际意义。